MBOT 8-K: LIBERTY® System Launch

Reported November 5, 2025.

Critical Update: Microbot Medical Inc. announced the limited commercial availability of its LIBERTY® Endovascular Robotic System in the United States.

• The initial rollout targets specific high procedure volume regions where prior interest was identified.
• This is a significant operational milestone.
• Note: This Form 8-K focuses solely on this business event; it does not include financial results or forward guidance updates. > Investors should note the launch is described as “limited basis.”

CEO Harel G